Antti Latvala Selected Research

Antti Latvala Research Topics

3	Substance-Related Disorders (Drug Abuse) 11/2022 - 03/2016
2	Tobacco Use Disorder (Nicotine Dependence) 03/2016 - 01/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023
1	Depressive Disorder (Melancholia) 01/2022
1	Venous Thromboembolism 01/2022
1	Alcohol-Related Disorders 02/2018
1	Mental Disorders (Mental Disorder) 12/2016
1	Cocaine-Related Disorders (Cocaine Addiction) 03/2016
1	Major Depressive Disorder (Major Depressive Disorders) 01/2014

2	drospirenone FDA LinkGeneric 01/2023 - 01/2022
2	CyproteroneIBA 01/2023 - 01/2022
2	etonogestrel (Implanon)FDA Link 01/2023 - 01/2022
1	Levonorgestrel (Plan B)FDA LinkGeneric 01/2023
1	ORALIT (ORS)IBA 11/2022
1	GestodeneIBA 01/2022
1	norelgestromin (LNGO)FDA Link 01/2022
1	Contraceptive Agents (Contraceptives)IBA 01/2022
1	Combined Oral ContraceptivesIBA 01/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Progestins (Progestagens)IBA 01/2022
1	Desogestrel FDA LinkGeneric 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2022
1	Cyproterone AcetateIBA 01/2022
1	Deoxyribonucleases (DNase)FDA Link 02/2018
1	Prednisolone (Predate)FDA LinkGeneric 12/2016
1	Opioid Analgesics (Opioids)IBA 03/2016
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2014

2	Female Contraceptive Devices (Vaginal Ring) 01/2023 - 01/2022
2	Hormonal Contraception 01/2023 - 01/2022
1	Transdermal Patch 01/2022
1	Contraception (Birth Control) 01/2022